Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

Presentation TCT 2016

Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More)

Presenter: Nicole Ibrahim, Martin B. Leon

November 01, 2016

Presentation TCT 2016

TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty

Presenter: Jean-Claude Laborde, Thomas Walther, Jalal Zamani

October 31, 2016

Presentation TCT 2016

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

Presenter: Mayra Guerrero, Roger J. Laham, Luis Nombela-Franco

October 31, 2016

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

Presentation TCT 2014

Balloon-Expandable Transcatheter Aortic Valves Can Be Effectively And Safely Implanted Transfemorally Without Balloon Valvuloplasty

Presenter: Suneil Aggarwal

September 16, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

Presentation TCT 2013

Trans-radial balloon aortic valvuloplasty

Presenter: Steven Goldberg, Creighton Don

January 31, 2013

Presentation TCT 2013

Predictors of Vascular complications in patients undergoing Balloon Aortic Valvuloplasty

Presenter: Annapoorna Kini, Roxana Mehran, Nilusha Gukathasan, Ziad Sergie, Mauricio Cohen, Jennifer Yu, Usman Baber, Samantha Sartori, Robert Pyo, Kleanthis Theodoropoulos, Roja Thapi, Elliot Elias, Socrates Kakoulides, Evan Jocobs, David knopf, Jason Kovacic, Raj Vadde, Brian O'Neill, Samin Sharma, George Dangas

January 31, 2013

News Conference News TCT 2012

PARTNER: Benefits of TAVR Sustained Out to 3 Years

October 25, 2012

Presentation TCT 2012

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Presenter: Felix Woitek

October 22, 2012

Presentation TCT 2012

Appropriate Use of Balloon Aortic Valvuloplasty in Aortic Stenosis Patients

Presenter: Helene Eltchaninoff

October 22, 2012

Presentation TCT 2012

Transcatheter aortic valve replacement with a self-expandable bioprosthesis performed without balloon valvuloplasty: comparative results in a consecutive series of patients

Presenter: Dimytri A. Siqueira, David LeBihan, Lucas Arraes, Alexandre A.C Abizaid, Rodrigo Barreto, Magali Arrais, Auristela Ramos, Manuel N. Cano, Antonio Kambara, Adriana C. Moreira, Jorge Assef, Fausto Feres, Eberhard Grube, Amanda GMR Sousa, J. Eduardo M.R. Sousa

January 03, 2012

Presentation TCT 2012

Balloon Aortic Valvuloplasty as a Bridging Thearpy to Aortic Valve Replacement or Transcatheter Aortic Valve Implantation

Presenter: Michael Tempelhof, Nirat Beohar, Chris S. Malaisrie, Patrick M. McCarthy, Charles J. Davidson

January 03, 2012

Presentation TCT 2012

B-Type Natriuretic Peptide Predicts Improvement of Left Ventricular Function and Clinical Outcome After Balloon Aortic Valvuloplasty.

Presenter: Joelle Kefer, Jean-Marie Gapira, Amer Harmouch, Jim Reish, Jean Renkin

January 03, 2012

News Conference News

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

November 09, 2011

News Conference News

BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty

November 07, 2011

Advertisement

Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More)

TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Balloon-Expandable Transcatheter Aortic Valves Can Be Effectively And Safely Implanted Transfemorally Without Balloon Valvuloplasty

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Trans-radial balloon aortic valvuloplasty

Predictors of Vascular complications in patients undergoing Balloon Aortic Valvuloplasty

PARTNER: Benefits of TAVR Sustained Out to 3 Years

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Appropriate Use of Balloon Aortic Valvuloplasty in Aortic Stenosis Patients

Transcatheter aortic valve replacement with a self-expandable bioprosthesis performed without balloon valvuloplasty: comparative results in a consecutive series of patients

Balloon Aortic Valvuloplasty as a Bridging Thearpy to Aortic Valve Replacement or Transcatheter Aortic Valve Implantation

B-Type Natriuretic Peptide Predicts Improvement of Left Ventricular Function and Clinical Outcome After Balloon Aortic Valvuloplasty.

PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 Years

BRAVO: Fewer Adverse Events with Bivalirudin vs. Heparin After Aortic Valvuloplasty

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content